BioSig Technologies closes $15 million public offering

BioSig Technologies Inc. (NASDAQ: BSGM) announced the closing of its underwritten public offering that raised approximately $15 million in gross proceeds. The company sold 3,852,149 shares of common stock at $3.90 per share without issuing warrants.

Clear Street and Needham & Company served as joint book-running managers for the offering. The transaction was conducted under a shelf registration statement that became effective with the Securities and Exchange Commission on December 17, 2024.

BioSig stated it plans to use the net proceeds to purchase gold bullion according to its investment policy, fund general corporate purposes and provide working capital. The company recently merged with Streamex Exchange Corporation, described as a gold tokenization infrastructure company.

"We now have been able to marry a short and long-term capital strategy for the company with high-quality shareholders to support this pivotal point in our development," said Henry McPhie, CEO of BioSig and Co-Founder of Streamex.

Streamex operates as a subsidiary focused on building infrastructure to bring gold markets onto blockchain platforms through tokenization technology and maintains a gold-denominated treasury.

BioSig Technologies traditionally operated in the medical device sector with its PURE EP Platform for cardiovascular treatments, though the recent merger has expanded its business focus to include gold-based digital assets.

The offering included participation from technology and mining industry participants, according to the company's statement.

You May Also Be Interested In

• Alpex Acquisition prices $100M IPO on Nasdaq
• Kadima sues NRx Pharmaceuticals over failed acquisition deal
• Hertz prices share lending deal tied to new debt offering